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Abstract
The development of molecules specific for M. tuberculosis-infected cells has important implications, as these tools
may facilitate understanding of the mechanisms regulating host pathogen interactions in vivo. In addition,
development of new tools capable to targeting M. tuberculosis-infected cells may have potential applications to
diagnosis, treatment, and prevention of tuberculosis (TB). Due to the lack of CD1b polymorphism, M. tuberculosis
lipid-CD1b complexes could be considered as universal tuberculosis infection markers. The aim of the present
study was to display on the PIII surface protein of m13 phage, a human ab single-chain T-cell receptor molecule
specific for CD1b:2-stearoyl-3-hydroxyphthioceranoyl-2´-sulfate-a-a´-D-trehalose (Ac2SGL) which is a complex
presented by human cells infected with M. tuberculosis. The results showed the pIII fusion particle was successfully
displayed on the phage surface. The study of the recognition of the recombinant phage in ELISA and
immunohistochemistry showed the recognition of CD1b:Ac2SGL complexes and cells in human lung tissue from a
tuberculosis patient respectively, suggesting the specific recognition of the lipid-CD1b complex.
Background
TB, caused by M. tuberculosis (Mtb), remains a leading
cause of morbidity and mortality, being responsible for
more than 2 million deaths every year [1]. Prevention of
transmission remains one of the most effective strategies
and therefore new tools useful for early and rapid diagno-
sis are urgently needed. Assays currently used to detect
specific T cell responses have shown several problems
including lack of response to used antigens, variations due
to concomitant infections and, last but not least, lack of
evidence of current presence of the infectious agent [2].
Lipids, glycolipids and lipopeptides derived from Mtb are
presented to T cells by non-polymorphic CD1 cell-surface
molecules [3,4], thus expanding the possible targets
available to the adaptive immune system for controlling
the infection. Presentation of lipid antigens to T cells has
been described in TB mediated by the presentation of
lipids in association with CD1b molecules [5]. A novel
lipid antigen belonging to the group of diacylated sulfogly-
colipids purified from Mtb (Ac2SGL) has been identified.
That Ac2SGL presented by CD1b molecules is recognized
by specific T cells that are present in TB patients and
PPD-positive, but not in PPD-negative individuals [3].
Taking into account that CD1b molecules are not poly-
morphic, Ac2SGL is expressed only by virulent mycobac-
teria, and that lipids are not subject to mutations induced
by selective pressure of the host immune system, the use
of CD1b:Ac2SGL complex as universal marker of tubercu-
losis infection should be evaluated. Phage display has been
instrumental for the success of antibody (Ab) technology
[6], but not fully expanded to TCRs [7]. The aim of the
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present study was, to display a functional ab scTCR recog-
nizing the CD1b:Ac2SGL complex from M. tuberculosis,
on the PIII protein of m13 phage.
Materials and methods
Total RNA from the human ab T-cell clone T Z4B27
recognizing the CD1b-Ac2SGL complex [3] was isolated
using the RNeasy kit from Qiagen according to the sup-
plied protocol. Total cDNA preparation was performed
using oligo(dT) primer and random primers together. The
TCR V-genes were amplified using selected primers [8].
TCR V-genes were sequenced by GeneArt (Germany). A
designed single chain TCR gene was synthesized by Gen-
eArt and cloned into the phagemid vector pHEN-1[9]
with standard techniques. The clone pHEN1-TCR was
transformed into a F´ suppressor TG1 E.coli strain to pro-
duce phage displaying the ab single-chain T-cell receptor.
Ac2SGL and the synthetic sulfoglycolipid analog
SGL12 were used to load recombinant human CD1b
molecules [3].
For the recognition test, 2x108 purified phage displaying
ab scTCR particles per well were tested by ELISA in
plates coated with human recombinant CD1b-Ac2SGL
complex, CD1b-SGL12, CD1b unloaded or Ac2SGL
alone [10].
Additionally the reactivity of these molecules by the
phages expressing the scTCR was checked through
immunohistochemistry using paraffin-embedded lung
tissues from HIV+ TB patients.
Results and discussion
The ability to display functional T-cell receptors on the
surface of bacteriophages could be used to develop new
strategies for isolating TCRs with unique specificity or to
carry out mutagenesis studies on TCR molecules for ana-
lyzing their structure–function. The sequences of variable
genes of the TCR of the human T-cell clone T Z4B27,
specific for M. tuberculosis sulfoglycolipid Ac2SGL, dis-
played by the CD1b molecule were obtained. To design a
ab scTCR the variable genes were linked by a flexible
hydrophilic peptide consisting in glycine and serine (Gly4-
Ser)3, which make it flexible and resistant to proteases [6].
The phagemid pHEN1 was selected to display the scTCR
linked to PIII protein of m13 phage. After gene cloning, a
colony PCR was performed in order to select recombinant
clones and the selected clones were confirmed by auto-
mated sequencing.
The phage displaying the ab scTCR recognized the
CD1b-loaded with Ac2SGL in ELISA (Fig.1). However,
the recognition of CD1b loaded with the synthetic
Figure 1 Binding specificity of phage displaying ab scTCR against CD1b-Ac2SGL complex. Phages were detected using an anti-m13
antibody linked to Horseradish Peroxidase enzyme. The empty phage pHEN1 and unloaded CD1b were used as negative controls.
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sulfoglycolipid analog SGL12 by the scTCR was lower
than the one obtained with CD1b loaded with the natural
sulfoglycolipid or Ac2SGL alone respectively (Fig.1).
SGL12 is able to activate the T-cell clone T Z4B27 but
with lower intensity than its natural counterpart Ac2SGL
[11]. In this regard, it should be considered that the struc-
tures of Ac2SGL and SGL12 are different [11]. One of the
differences is related with the -OH methyl groups of the
lipid tails which plays an important role in the recognition
of CD1b-lipid complex by the TCR[12].
T-cell activation needs the interaction of the TCR
with the polar residues of lipids and with the amino
acids from the CD1b-groove, so the recognition of free
Ac2SGL by the scTCR (Fig.1) could be mediated by the
interaction of the scTCR with polar structures of
Ac2SLG recognized by the TCR of the T cell clone.
In general, the signals obtained in ELISA could be
considered relatively low. These results could be
explained if we take into account that the interaction of
T cell receptors with their ligands are not of high affi-
nity [13].
The figure 2A shows multinucleated Langhans giant
cells stained inside a defined granuloma formed by a
central necrotic core surrounded by concentric layers of
cells in a tissue section probed with the phage displaying
the scTCR specific for the Ac2SGL:CD1b complex. No
signal was detected using the control phagemid pHEN1.
This result suggested the recognition of Mtb infected
cells in tissues by the scTCR.
In summary our data show a functional TCR as a
scTCR-PIII fusion displayed by the m13 phage that recog-
nize the sulfoglycolipid antigen Ac2SGL from Mtb and
discriminated between the CD1b loaded or unloaded with
the Ac2SGL molecule. Additionally, the scTCR can differ-
entiate the CD1b loaded with the natural antigen Ac2SGL
or loaded with the synthetic analogue SGL12. The recom-
binant phage also recognized cells, probably infected with
Mtb, in lung tissues from a HIV+ TB patient.
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Figure 2 Immunoperoxidase staining of a lung section from a TB patient by a phage expressing scTCR specific for CD1b-Ac2SGL
complex. The phage displaying scTCR molecules were detected by staining with a mouse anti-m13 monoclonal antibody conjugated
to horseradish peroxidase. Positive cells are indicated by arrows. Micrographs are shown at a magnification of, A: 160 x ; B: 240 x.
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